Veterinary Point of Care Diagnostics Market Size & Share 2025 – 2034

Veterinary Point of Care Diagnostics Market Size

The global veterinary point of care diagnostics market was valued at USD 2.4 billion in 2024. The market is expected to grow from USD 2.6 billion in 2025 to USD 6.2 billion in 2034, growing at a CAGR of 10.2% over the analysis period. The rising prevalence of infectious diseases in animals is a major driver in the market.

Moreover, this increasing prevalence of zoonotic and transboundary diseases further contributes to the market growth. For example, according to the report published by the NIH, about 60% of all known human infectious diseases are zoonotic, and around 75% of emerging infectious diseases are of animal origin. Furthermore, the increasing prevalence of infectious diseases in companion animals, such as parvovirus, feline leukaemia, and heartworm, increases the demand for diagnostic tools that help in early diagnosis of the disease.
 

Additionally, the rising population of both companion and livestock animals further contributes to the increased demand for effective diagnostic tools. As per the World Animal Foundation estimates, the companion animal population reached approximately 967 million worldwide, of which 522 million were dogs and 445 million were cats.  Similarly, according to FAO, the global ruminant livestock population is roughly 3.6 billion, of which approximately 2 billion represents the total number of livestock animals used for meat and dairy products. Further, the global poultry population has reached an astounding 26 billion. Such a high volume of animals increases the demand for various animal healthcare products and veterinary services, including diagnostic solutions, thereby boosting the market growth.
 

Furthermore, availability of advanced medical facilities for pets, cutting-edge diagnostic laboratories, increasing number of veterinary hospitals and clinics, and high adoption of pet insurance are further set to positively impact the industry growth. In addition, several technological advancements in the field of veterinary medicine are set to positively influence the veterinary point of care diagnostics industry. For example, MARS has an AI technology that helps with the prediction of the genetic ancestry of animals. Additionally, AI and IoT are being used for livestock management that ensures the health and well-being of the livestock. Such advances increase the credibility of point of care diagnostic solutions, thereby increasing their adoption rates.
 

Veterinary point of care diagnostics refers to diagnostic tools and technologies that help in the early detection of diseases and on-site testing of health conditions that provide a real-time result, further helping the veterinarians and farmers to make treatment decisions for the well-being of the animals. Diagnosis helps in the reduction of treatment time and improves animal health, which drives the market. Moreover, the increasing advancements in diagnostic technology have resulted in improved animal health outcomes, better health management, and cost-effective care of animals.
 

Veterinary Point of Care Diagnostics Market Trends

• The growth of the market is significantly escalated by technological advancements, the introduction of advanced diagnostic tools, and rising veterinary healthcare expenditure.
   
• For instance, the introduction of rapid diagnostics tests, such as DRIT for rabies diagnostics, LAMP PCR device, and others, has significantly reduced the time required to detect diseases in animals. These tests have enabled rapid and accurate diagnosis, allowing veterinarians to provide quick treatments.
   

• Further, the increasing occurrence of zoonotic diseases as well as the possibility of infectious outbreaks in companion and livestock animals have been propelling the market. There are stricter policies pertaining to the health of animals due to concerns regarding food security globally. These policies have led to the implementation of various animal health and wellness programs aimed at ensuring disease control.
   
• Regulatory authorities across the world are imposing strict policies to prevent the outbreak of animal-borne diseases by implementing stricter diagnosis and treatment policies, thus contributing to the overall market growth.
   
• Moreover, high adoption of pet insurance is expected to be an instrumental factor in driving the market expansion. According to the North American Pet Health Insurance Association, there has been an increase of about 18% in the number of insured pets during 2017-2018, in the U.S. Further, the number of insured pets in 2021 was 26% higher than in 2020 and 63% higher than in 2018. Thus, surging demand for pet insurance coupled with the growing number of insured animals will drive the market expansion.
   
• Technological advancements have significantly enhanced the accuracy, efficiency, and scope of veterinary POC diagnostic solutions, enabling early disease detection and improved treatment outcomes.
   
• Leading players such as Zoetis, IDEXX Laboratories, and MiDOG Animal Diagnostics are focusing on point-of-care (POC) veterinary molecular diagnostic solutions, allowing pet owners and veterinarians to access real-time results for infectious disease screening, blood chemistry analysis, and hormone testing.
   
• In June 2022, IDEXX Laboratories expanded its reference laboratory menu by introducing Next-Day PCR Direct Testing Service, improving diagnostic turnaround times. Such initiatives by key market players will further strengthen the market growth.
   
• Lastly, the incorporation of artificial intelligence (AI) and machine learning (ML) has improved disease management. AI algorithm helps analyse patient health, such as vital signs and laboratory results, to detect early signs of any disease and predict its progression. Therefore, these innovations are expected to play a crucial role in increasing the growth and effectiveness of veterinary point of care diagnostics in the market during the analysis period.
   

Veterinary Point of Care Diagnostics Market Analysis

In 2021, the global market was valued at USD 1.8 billion. The following year, it saw a slight increase to USD 2 billion, and by 2023, the market further climbed to USD 2.1 billion.
 

Based on the product, the global market is divided into consumables and instruments and devices. The consumables segment dominated the market in 2024 and was valued at USD 1.6 billion.
 

• Unlike instruments and devices, consumables such as kits and reagents, cartridges, and assays are used in every POC test, leading to continuous replenishment needs. Hence, as the veterinary testing volume rises, so does the demand for these consumables. This ensures steady revenue and growth in the consumables used in the veterinary field.
   
• Furthermore, the rising frequency of animal disease outbreaks has increased the demand for diagnostic testing. For example, as per the World Organization for Animal Health (WOAH), over 3,500 highly pathogenic avian influenza outbreaks were reported across 67 countries in 2022, a 35% increase from 2021. Further, the U.S. Department of Agriculture (USDA) reported that bovine viral diarrhea (BVD) testing volumes increased by 28% between 2021 and 2023 in commercial cattle operations. Such increasing prevalence of infectious diseases necessitates testing, thus increasing the demand for various consumables.
   
• Furthermore, with the increasing number of veterinary clinics, hospitals, and diagnostic laboratories, the need for portable and easy-to-use diagnostic consumables has grown. These offer convenience and reduce waiting times, which further increases the segment growth.
   

Based on the test type, the global veterinary point of care diagnostics market is categorized into clinical biochemistry, immunodiagnostics, molecular diagnostics, haematology, urinalysis, and other test types. The clinical biochemistry segment dominated the market with 35.1% market share in 2024.
 

• The clinical biochemistry segment dominates the market due to its critical role in testing and monitoring conditions, including metabolic disorders, infections, and organ dysfunction.
   
• Major tests, such as liver and kidney function tests, electrolyte panels, and blood glucose monitoring, are essential for evaluating sepsis and other critical conditions. Clinical biochemistry is central to the early detection and management of sepsis by identifying biomarkers that indicate organ failure, infection, or inflammation.
   
• The clinical biochemistry tests are widely used in various hospitals, diagnostic labs and point of care facilities. These tests are used for accurate and rapid results that help in the detection of metabolic disorders, infections, organ dysfunction, endocrine disorders, electrolyte imbalances, inflammation and immune system disorders.
   

Based on the animal type, the global veterinary point of care diagnostics market is categorized into companion animals and livestock animals. The companion animals segment dominated the market in 2024 and is anticipated to witness growth at a CAGR of 10.3%. The segment includes animals such as dogs, cats, horses, and other companion animals.
 

• This substantial growth is attributed to the rising adoption rate of animals such as dogs, cats, birds, and horses as pets.
   
• More than half of the global population is estimated to have a pet at home. Globally, dogs are the most popular pet, present in around one in three homes. Almost a quarter of pet owners have a cat. Thus, the sheer number of companion animals, along with increased spending, is expected to propel the segmental growth.
   
• Furthermore, the American Veterinary Medical Association reported a 12% increase in veterinary visits between 2021 and 2023, with diagnostic testing accounting for 25% of all veterinary procedures. This growth has expanded the market for POC diagnostic tests tailored to companion animals.
• Further, growing disposable income in developing economies and the launch of advanced animal healthcare products will spur segment growth during the forecast timeframe.
   

Based on the sample type, the global veterinary point of care diagnostics market is categorized in blood/plasma/serum, urine, faecal, and other sample types. The blood/plasma/serum segment dominated the market in 2024 and is expected to reach USD 3 billion by 2034.
 

• Increasing testing volumes of blood, plasma, and serum in veterinary diagnostics is stimulated by their ability to provide critical information for diagnosing a wide range of conditions. These biological samples are trustworthy and offer a vast range of insights for the animal's health status, making them important and essential for effective and rapid diagnosis.
   
• These samples are essential for conducting various diagnostic tests such as hematology, biochemistry, and serology, which are critical for detecting infections, organ dysfunction, and metabolic disorders in animals.
   
• Their ease of collection, even in field settings, and compatibility with compact, portable analyzers make them a preferred choice among veterinarians.
   

Based on the application, the global veterinary point of care diagnostics market is categorized into infectious diseases, non-infectious conditions, hereditary and congenital conditions, acquired health issues, and other applications. The infectious diseases segment dominated in 2024 and was valued at USD 1 billion.
 

• Infectious diseases, including bovine viral diarrhoea (BVD), foot-and-mouth disease, canine parvovirus, and feline leukaemia, affect multiple animal species. For instance, according to the World Organization for Animal Health (WOAH), in 2023, over 8,500 outbreaks of foot-and-mouth disease were reported across 23 countries.
   
• In addition, the American Veterinary Medical Association documented a 12% increase in canine parvovirus cases between 2021 and 2023. These diseases significantly impact animal health, productivity, and survival rates.
   
• POC diagnostic methods enable early detection, which is essential for effective outbreak management. The continuous risk of these diseases increases the demand for precise diagnostic tools.
   
• Moreover, livestock and companion animals are susceptible to various infectious diseases, including parvovirus, bovine viral diarrhoea (BVD), avian influenza, and leptospirosis. These conditions can lead to serious health complications and considerable economic losses.
   
• The high prevalence of such diseases necessitates rapid and accurate diagnostic solutions, thereby driving segmental growth.
   

Based on the end use, the global veterinary point of care diagnostics market is segmented into veterinary hospitals and clinics, diagnostic labs, home care settings, and other end users. The veterinary hospitals and clinics segment dominated the market in 2024 and was valued at USD 1.1 billion.
 

• Veterinary hospitals and clinics hold a dominant share in the market because of their sophisticated infrastructure, trained personnel, and capability to efficiently manage large sample volumes with high accuracy.
   
• The growing adoption of point of care diagnostics in these settings is advanced by the need for accurate results to provide immediate care, improving clinical outcomes and supporting the overall health of animals.
   
• Veterinary hospitals and clinics enable quick and precise diagnoses, shortening the time to treatment for various conditions. The need for rapid diagnosis in these settings further increases the adoption of veterinary POC solutions.
   

The North America veterinary point of care diagnostics market dominated the global market with a market share of 43.6% in 2024. The market is stimulated by the increasing incidence of animal diseases and the growing demand for rapid and on-site diagnostics. Advancements in point-of-care testing technologies and a rising focus on early and accurate diagnosis in both companion and livestock animals also support market growth.
 

The U.S. market was valued at USD 712 million and USD 779.9 million in 2021 and 2022, respectively. The market size reached USD 939.4 million in 2024, growing from USD 855.4 million in 2023.
 

• High rates of pet ownership in the country, coupled with the availability of advanced pet care services, drive market growth.
   
• For instance, as of 2023, over 66% of Americans, which translates to about 87 million homes, owned at least one pet. Also, the region has a strong livestock industry, which further increases the demand for veterinary diagnostics.
   
• Additionally, rising expenditure on animal care and strong veterinary infrastructure increases the adoption of veterinary point of care diagnostics.
   
• Also, the high adoption of pet insurance in the region contributes to the overall market growth.  
   

Europe veterinary point of care diagnostics market accounted for USD 605.8 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising awareness and adoption of rapid animal health diagnostics, along with increasing government initiatives to control zoonotic and livestock diseases, is anticipated to spur growth in the veterinary point-of-care diagnostics market.
   
• Moreover, advancements in diagnostic technologies, such as microfluidics, immunoassay platforms, and portable molecular testing devices, along with the introduction of affordable and field-deployable solutions, boost the adoption of veterinary point-of-care diagnostics in the region.
   
• Also, the presence of key market players in the region strengthens the market. These companies actively participate in innovation through the development of next-generation diagnostic tools and partnerships with veterinary organizations and rural outreach programs, thereby advancing market growth.
   

Germany veterinary point of care diagnostics market is anticipated to witness considerable growth over the analysis period.
 

• The country’s well-established veterinary practices and research institutions, along with its emphasis on high-quality veterinary services, contribute to the widespread adoption of veterinary point of care diagnostics technology.
   
• The rising adoption of pet and livestock animals, coupled with surging expenditure on veterinary care, is also set to augment the market in Germany.
   
• For example, as of 2023, 45% of German households have a pet and 14% of households have two pets or more. This totals approximately 34.3 million pets. Cats and dogs are the most popular house pets, with 25% of German households owning cats and 21% of households owning dogs. Moreover, in 2024, the cattle population in Germany was 10.63 million. Such a high volume of pets and livestock animals increases the demand for effective diagnostic solutions, thus boosting market growth.
   

The Asia Pacific veterinary point of care diagnostics market is anticipated to grow at the highest CAGR of 10.7% during the analysis timeframe.
 

• The market in the Asia Pacific region is growing rapidly due to the rise in animal disease outbreaks, increasing awareness of veterinary healthcare, and the improvement of diagnostic infrastructure across both urban and rural veterinary settings.
   
• Countries such as China, India, and Japan are adopting veterinary point of care diagnostics at a faster rate due to enhanced demand for early disease detection, government-led animal health initiatives, and the rise in mobile veterinary services targeting underserved areas.
   
• Additionally, the rapid rise in the number of veterinary clinics and mobile diagnostic units, along with government policies aimed at expanding animal health services and integrating PoC diagnostics into national livestock and pet healthcare programs, contributes to the rapid growth of the veterinary point-of-care diagnostics market in the region.
   

India veterinary point of care diagnostics market is predicted to grow significantly over the forecast period.
 

• India has a large pet population with over 31 million pet dogs and 2.44 million pet cats. The increasing pet ownership and rising disposable income in the country, coupled with high expenditure on pet healthcare, will offer lucrative market growth opportunities in the country.
   
• In addition, rapidly expanding veterinary infrastructure in the country such as veterinary hospitals and clinics, will further enhance the market growth.
   
• Furthermore, several government initiatives to support animal health and wellness also stimulate the market growth. For instance, the National Animal Disease Control Programme is a flagship scheme launched in 2019 that aims to control the spread of various animal diseases by increasing testing and disease monitoring. Such initiatives will further drive the market growth.
   

Brazil is experiencing significant growth in the Latin America veterinary point of care diagnostics market due to the increasing demand for advanced diagnostic tools in veterinary care.
 

• Brazil holds a leading position in the Latin American market, driven by its substantial livestock industry, increasing pet ownership, and advancements in veterinary diagnostics.
   
• Brazil has the third-largest pet population in the world, with 160 million pets, of which 60 million are dogs, 30 million cats, and 32 million pet-owning households.
   
• The country is also home to a large livestock population, with Brazil being the third-largest cattle producer and second-largest beef exporter in the world.
   
• Such high animal volume, coupled with strong growth in veterinary expenditure, is anticipated to foster market growth.
   
• Additionally, the country's significant demand for animal-derived food products, government initiatives to enhance agricultural and animal health outcomes, and a rising incidence of zoonotic diseases further boost the market growth.
   

South Africa veterinary point of care diagnostics market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• About 45% of adults in South Africa are pet owners, showcasing the country’s love for animals. Among these, 78% are dog owners, while only 36% own cats.
   
• The increasing pet ownership in the country, rising disposable income, coupled with a rapidly expanding veterinary infrastructure, will offer lucrative market growth opportunities in the country.
   
• Additionally, high prevalence of infectious diseases such as rabies and influenza increases the risk of complications, further stimulating demand for effective diagnosis and focused care of animals.
   

Veterinary Point of Care Diagnostics Market Share

Competition in the veterinary point of care diagnostics industry is marked by well-established companies, emerging firms, and local players fighting to capture a larger share of the market. Top 6 players such as Zoetis, Virbac, Thermo Fisher, Mindray, Fujifilm, and Idexx Laboratories account for approximately 60%-70% of the market share. These key players focus on various strategies such as acquisitions, business expansion and novel product launches to consolidate their market presence.
 

Additionally, there are several local and regional players operating in the market who are boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Veterinary Point of Care Diagnostics Market Companies

Few prominent players operating in the veterinary point of care diagnostics industry includes:

• Antech
• BioMerieux
• Biotangents
• Carestream Health
• Esaote
• Eurolyser Diagnostica
• FUJIFILM SonoSite
• GE Healthcare
• IDEXX Laboratories
• Mindray
• NeuroLogica
• Randox Laboratories
• Thermo Fisher Scientific
• Virbac
• Woodley Equipment
• Zoetis
   
• IDEXX Laboratories is a leading player in the veterinary point-of-care (POC) diagnostics market, offering a comprehensive portfolio of rapid diagnostic tests, analyzers, and digital solutions. Its in-house testing platforms, like Catalyst One, ProCyte Dx, and SNAP tests enable real-time results for clinics and hospitals. The company's strong global presence, innovation-driven approach, and focus on companion animal health contribute significantly to its dominant market share.
   
• Zoetis is a leading player in the veterinary point-of-care (POC) diagnostics market, offering a comprehensive portfolio of diagnostic solutions tailored for companion and livestock animals. Its POC offerings include diagnostic devices like the Vetscan analyzers, which enable rapid, on-site testing for blood chemistry, hematology, and infectious diseases. The company's focus on innovation, integration with digital platforms, and strong global distribution network enhances its position in the market.
   

Veterinary Point of Care Diagnostics Industry News

• In January 2025, Zoetis launched the Vetscan OptiCell, a new screenless point-of-care hematology analyzer that is the first cartridge-based, artificial intelligence (AI) powered diagnostic tool for veterinary hematology. This innovative device provides complete blood count (CBC) analysis with reference lab quality accuracy in just minutes, offering accurate and reliable hematology insights to veterinary professionals.
   
• In January 2024, Idexx Laboratories launched its slide-free cellular analyser named the IDEXX Invue Dx. This technology improved point of care diagnosis by eliminating the traditional slide use with a rapid and high-quality diagnosis. It is used to detect the most common cytologic changes found in ear and blood samples. This helped the company expand its product offerings.
   
• In June 2023, Mars Petcare acquired Heska, this acquisition enabled Mars Petcare to expand its capabilities in offering point of care diagnostics for animals. With this acquisition, the company improved its veterinary diagnostic offerings. This helped the company expand its presence in veterinary POC diagnostics market.  
   
• In March 2022, VolitionRx Limited (Volition) announced that it has signed an exclusive global supply and license agreement with Heska Corporation (Heska) to sell Volitions Nu. Q Vet Cancer Screening test. This strategy is expected to enhance their long-term relationship as well as outreach to untapped economies.
   

The veterinary point of care diagnostics market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Consumables
• Instruments and devices

Market, By Test Type

• Clinical biochemistry
• Immunodiagnostics
• Molecular diagnostics
• Hematology
• Urinalysis
• Other test types

Market, By Animal Type

• Companion animals 
  • Dogs
  • Cats
  • Horses
  • Other companion animals
•    Livestock animals 
  • Cattle
  • Swine
  • Poultry
  • Other livestock animals

Market, By Sample Type

• Blood/plasma/serum
• Urine
• Fecal
• Other sample types

Market, By Application

• Infectious diseases
• Non-infectious conditions
• Hereditary and congenital conditions
• Acquired health conditions
• Other applications

Market, By End Use

• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudia Arabia
  • UAE